Prospera Financial Services Inc grew its holdings in CME Group Inc (NASDAQ:CME) by 24.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,646 shares of the financial services provider’s stock after buying an additional 319 shares during the period. Prospera Financial Services Inc’s holdings in CME Group were worth $307,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Moors & Cabot Inc. acquired a new stake in CME Group during the 1st quarter worth approximately $204,000. ETF Managers Group LLC lifted its holdings in CME Group by 9.5% during the 1st quarter. ETF Managers Group LLC now owns 898 shares of the financial services provider’s stock worth $148,000 after purchasing an additional 78 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its holdings in CME Group by 67.2% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 43,039 shares of the financial services provider’s stock worth $7,083,000 after purchasing an additional 17,303 shares during the last quarter. Commerce Bank lifted its holdings in CME Group by 0.6% during the 1st quarter. Commerce Bank now owns 510,954 shares of the financial services provider’s stock worth $84,093,000 after purchasing an additional 3,197 shares during the last quarter. Finally, Cambria Investment Management L.P. lifted its holdings in CME Group by 8.5% during the 1st quarter. Cambria Investment Management L.P. now owns 24,546 shares of the financial services provider’s stock worth $4,040,000 after purchasing an additional 1,916 shares during the last quarter. 84.85% of the stock is owned by institutional investors.
In other news, CFO John W. Pietrowicz sold 2,500 shares of CME Group stock in a transaction on Tuesday, July 9th. The stock was sold at an average price of $201.30, for a total value of $503,250.00. Following the transaction, the chief financial officer now owns 32,854 shares in the company, valued at approximately $6,613,510.20. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total value of $7,005,250.00. Following the completion of the transaction, the chief executive officer now owns 79,057 shares in the company, valued at approximately $15,823,258.55. The disclosure for this sale can be found here. Insiders sold a total of 59,626 shares of company stock valued at $12,255,934 over the last ninety days. Insiders own 1.20% of the company’s stock.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.01. The firm had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The company’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.74 EPS. On average, equities analysts anticipate that CME Group Inc will post 6.73 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 annualized dividend and a yield of 1.41%. CME Group’s dividend payout ratio is presently 43.99%.
CME has been the subject of several research reports. UBS Group lifted their price target on CME Group from $191.00 to $214.00 and gave the stock a “neutral” rating in a report on Thursday, September 5th. Oppenheimer initiated coverage on CME Group in a report on Monday. They set an “outperform” rating and a $234.00 price target for the company. Berenberg Bank cut CME Group from a “buy” rating to a “hold” rating and dropped their price target for the stock from $236.00 to $227.00 in a report on Thursday. Wells Fargo & Co lifted their price target on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a report on Wednesday, July 3rd. Finally, Deutsche Bank lifted their price target on CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a report on Friday, August 9th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $200.00.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Further Reading: What is Call Option Volume?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.